Angiogenesis inhibitor TNP-470 suppresses tumorigenesis in rat urinary bladder

Journal of Urology

Volumn 157, Issue 2, 1997, Pages 683-688

  Tanaka, Yoshinori ^a   Kawamata, Hitoshi ^a   Fujimoto, Kiyohide ^a   Oyasu, Ryoichi ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

angiogenesis; bladder carcinogenesis; endothelial cells; heterotopically transplanted rat urinary bladder; TNP 470

Indexed keywords

ANGIOGENESIS INHIBITOR; CARCINOGEN; DIMETHYL SULFOXIDE; DRUG VEHICLE; FUMAGILLOL CHLOROACETYLCARBAMATE; METHYLNITROSOUREA; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CARCINOGENESIS; BLADDER TUMOR; CANCER INCIDENCE; CANCER INHIBITION; CAPILLARY ENDOTHELIUM; CATTLE; CELL GROWTH; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TOPICAL DRUG ADMINISTRATION;

EID: 0031012598     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65250-9     Document Type: Article

References (31)

1. Catalona, W. J.: Urothelial tumors of the urinary tract. In: Campbell's Urology. Sixth edition. Edited by P. C. Walsh, A. B. Retik, T. A. Stamey and E. D. Vaughan, Jr. Philadelphia: W. B. Saunders Company, vol. 2, chapt. 28, pp. 1094-1158, 1992.
2. Malmström, P. U., Busch, C. and Norlén, B. J.: Recurrence, progression and survival in bladder cancer: a retrospective analysis of 232 patients with greater than or equal to 5-year follow up. Scand. J. Urol. Nephrol., 21: 185, 1987.
3. Gilbert, H. A., Logan, J. L., Kagan, A. R., Friedman, A. R., Cove, J. K., Fox, M., Muldoon, T. M., Lonni, Y. W., Rowe, J. H., Cooper, J. F., Nussbaum, H., Chan, P., Rao, A. and Starr, A.: The natural history of papillary transitional cell carcinoma of the bladder and its treatment in an unselected population on the basis of histologic grading. J. Urol., 119: 488, 1978.
4. Althausen, A. F., Prout, G. R., Jr. and Daly, J. J.: Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J. Urol., 116: 575, 1976.
5. Lutzeyer, W., Rübben, H. and Dahm, H.: Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. J. Urol., 127: 250, 1982.
6. Folkman, J.: The role of angiogenesis in tumor growth. Cancer Biol., 3: 65, 1992.
7. Liotta, L., Kleinerman, J. and Saidel, G.: Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastasis following tumor implantation. Cancer Res., 34: 997, 1974.
8. Varkarakis, M. J., Gaeta, J., Moore, R. H. and Murphy, G. P.: Superficial bladder tumor: aspects of clinical progression. Urology, 4: 414, 1974.
9. Tatematsu, M., Cohen, S. M., Fukushima, S., Shirai, T., Shinohara, Y. and Ito, N.: Neovascularization in benign and malignant urinary bladder epithelial proliferative lesions of the rat observed in situ by scanning electron microscopy and autoradiography. Cancer Res., 38: 1792, 1978.
10. Cohen, S. M., Tatematsu, M., Shinohara, Y., Nakanishi, K. and Ito, N.: Neovascularization in rats during urinary bladder carcinogenesis induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide. J. Natl. Cancer Inst., 65: 145, 1980.
11. Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H. and Folkman, J.: Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature (Lond.), 348: 555, 1990.
12. Kusaka, M., Sudo, K., Fujita, T., Marui, S., Itoh, F., Ingber, D. and Folkman, J.: Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem. Biophys. Res. Commun., 174: 1070, 1991.
13. Kawamata, H., Kameyama, S., Nan, L., Kawai, K. and Oyasu, R.: Effect of epidermal growth factor and transforming growth factor β1 on growth and invasive potentials of newly established rat bladder carcinoma cell lines. Int. J. Cancer, 55: 968, 1993.
14. Carmichael, J., DeGraff, W. G., Gazdar, A. F., Minna, J. D. and Mitchell, J. B.: Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res., 47: 936, 1987.
15. Rastinejad, F., Polverini, P. J. and Bouck, N. P.: Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell, 56: 345, 1989.
16. Oyasu, R., Manning, D. J., Matsumoto, M. and Hopp, M. L.: Heterotopic urinary bladder with a communicating reservoir. Cancer Res., 36: 2261, 1976.
17. Hirao, Y., Izumi, K. and Oyasu, R.: The effect of normal rat urine on mucosal regeneration in heterotopic urinary bladder. Lab. Invest., 42: 76, 1980.
18. Miyata, Y., Babaya, K. and Oyasu, R.: Carcinogenesis in heterotopically-transplanted urinary bladder by N-methyl-N-nitrosourea: a model for initiation and promotion. Carcinogenesis, 2: 495, 1981.
19. Samma, S. and Oyasu, R.: Conversion from low grade to high grade of rat urinary bladder carcinomas. Cancer Res., 48: 1265, 1988.
20. Oyasu, R., Samma, S., Ozono, S., Bauer, K., Wallemark, C. B. and Homma, Y.: Induction of high-grade, high-stage carcinomas in the rat urinary bladder. Cancer (Phila.), 59: 451, 1987.
21. Yanase, T., Tamura, M., Fujita, K., Kodama, S. and Tanaka, K: Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res., 53: 2566, 1993.
22. Yamaoka, M., Yamamoto, T., Masaki, T., Ikeyama, S., Sudo, K. and Fujita, T.: Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetylcarbamoyl) fumagillol (TNP-470; AGM-1470). Cancer Res., 53: 4262, 1993.
23. Yamaoka, M., Yamamoto, T., Ikeyama, S., Sudo, K. and Fujita, T.: Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines. Cancer Res., 53: 5233, 1993.
24. Kato, T., Sato, K., Kakinuma, H. and Matsuda, Y.: Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl) fumagillol (TNP-470) and cytotoxic agents in mice. Cancer Res., 54: 5143, 1994.
25. Mori, S., Ueda, T., Kuratsu, S., Hosono, N., Izawa, K. and Uchida, A.: Suppression of pulmonary metastasis by angiogenesis inhibitor TNP-470 in murine osteosarcoma. Int. J. Cancer, 61: 148, 1995.
26. Tanaka, T., Konno, H., Matsuda, I., Nakamura, S. and Baba, S.: Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP-470. Cancer Res., 55: 836, 1995.
27. Konno, H., Tanaka, T., Matsuda, I., Kanai, T., Maruo, Y., Nishino, N., Nakamura, S. and Baba, S.: Comparison of the inhibitory effect of angiogenesis inhibitor, TNP-470, and mitomycin C on the growth and liver metastasis of human colon cancer. Int. J. Cancer, 61: 268, 1995.
28. Kusaka, M., Sudo, K., Matsutani, E., Kozai, Y., Marui, S., Fujita, T., Ingber, D. and Folkman, J.: Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). Br. J. Cancer, 69: 212, 1994.
29. Hori, A., Ikeyama, S. and Sudo, K.: Suppression of cyclin D1 mRNA expression by the angiogenesis inhibitor TNP-470 (AGM-1470) in vascular endothelial cells. Biochem. Biophys. Res. Comm., 204: 1067, 1994.
30. Brem, H., Ingber, D., Blood, C. H., Bradley, D., Urioste, S. and Folkman, J.: Suppression of tumor metastasis by angiogenesis inhibition. Surg. Forum, 42: 439, 1991.
31. Folkman, J. and Shing, Y.: Angiogenesis. J. Biol. Chem., 267: 10931, 1992.